Mitchell C. Benson

Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer

Daniel P. Petrylak, Catherine M. Tangen, Maha Hussain et al. · New England Journal of Medicine · 2004 · 3.7K citations · Full text

Pharmacy, Oncology, Pharmacotherapy +13

Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer

Suk Hyung Lee, Wenhuo Hu, Justin T. Matulay et al. · Cell · 2018 · 872 citations · Full text

Medicine, Cancer Biology, Oncology +17

Prostate Specific Antigen Density: A Means of Distinguishing Benign Prostatic Hypertrophy and Prostate Cancer

Mitchell C. Benson, Ihn Seong Whang, Allan J. Pantuck et al. · The Journal of Urology · 1992 · 773 citations

Medicine, Oncology, Urology +17

The Use of Prostate Specific Antigen Density to Enhance the Predictive Value of Intermediate Levels of Serum Prostate Specific Antigen

Mitchell C. Benson, Ihn Seong Whang, Carl A. Olsson et al. · The Journal of Urology · 1992 · 611 citations

Medicine, Oncology, Urology +17

Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers.

Marc Colombel, Fraser Symmans, Sixtina Gil et al. · PubMed · 1993 · 595 citations

Medicine, Cancer Biology, Oncology +14